Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China

BMC Cancer

Han Bao¹  Dan Liu¹  Hao Jiang¹  Shaofei Su¹  Meiqi Zhang¹  Jiaying Wang¹  Meina Liu¹  Xinyu Wang¹  Shouyi Li² 

[1] Department of Biostatistics, Public Health College, Harbin Medical University;People’s Hospital of Jilin Province;

关键词: Quality indicators;    Quality of care;    Lung cancer;    Chinese health system;   

DOI  :  10.1186/s12885-017-3602-0

来源: DOAJ

【 摘 要 】

Abstract Background Large gap exists between clinical practice and recommended care and large room exists for the improvement of care quality for non-small cell lung cancer (NSCLC) in China. Results of some studies have shown that assessment of care quality can help to make improvement and the development of quality indicators is deemed as the initial and most essential part. Yet there is no such an indicators system specifically suitable for Chinese health care system. The goal of the study is to set up a group of Chinese quality indicators for NSCLC care and make it the first step towards the improvement of NSCLC care quality in China. Methods We constructed a new indicator framework based on the characteristics of NSCLC care and the nature of Chinese health care system. Under the new framework, potential indicators were collected and a 3-round modified Delphi process was conducted by a national multi-disciplinary Expert Panel to develop a set of indicators until they reached the final consensus. Results A new indicator framework (structure, process, communication, management of symptoms or treatment toxicity and outcome) was developed. Seventy four indicators were extracted from guidelines and relevant literatures as potential indicators; 43 indicators plus 1 suggested indicator were remained after the discussion of Round 1; questionnaires of Round 2 were rated by Expert Panel and 19 indicators met the inclusion criteria and entered Round 3; 2 of the eliminated indicators in Round 2 were retrieved by the Expert Panel at the in-person meeting (Round 3). Therefore, 21 indicators got the final consensus of the Expert Panel. Conclusions Guided by the new indicator structure, a set of indicators suitable for Chinese healthcare system was developed and can be utilized to measure and improve the care quality of non-small cell lung cancer.

【 授权许可】

Unknown